Sign In
Toggle Dropdown
Advanced Search
Sign In
About Us
Help
Contact
Close
Site Menu
MLex Watch Home
FTCWatch
About
Who We Are
Contact Us
FAQ - Help
Sign up for our newsletters
Terms
Privacy Policy
Order final: Divestiture on the clock
( June 15, 2011) -- Hikma Pharmaceuticals may acquire Baxter Healthcare Corporation’s generic injectables business, a $112 million proposed deal that the FTC approved on June 7....
Related Sections
FTCWatch
×
Cooley LLP users
Click Here to Sign In
×
Sign up for our FTCWatch newsletter
You must correct or enter the following before you can sign up:
Please provide a professional email:
Select more newsletters to receive for free
FTCWatch
FTCWatch takes your privacy seriously. Please see our
Privacy Policy
.
No Thanks
Sign up now
Thank You!